After a grueling two years of high inflation and elevated interest rates, Americans are finally set for some relief: Federal Reserve Chair…
Shares of Snowflake (NYSE:SNOW) fell sharply after the cloud-focused software company reported earnings for its second fiscal quarter, which on one hand…
Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. One of…
Walmart is hoping Burger King will give its subscription program a whopper of an advantage over Amazon. The retailer is partnering with…
Ultragenyx's Strong Pipeline And Valuation Concerns: A Balanced Perspective (NASDAQ:RARE)
By Press Room
6 Mins read
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) develops innovative therapies for rare and ultra-rare genetic diseases. Its commercial portfolio includes Crysvita, Mepsevii, Dojolvi, and Evkeeza,…
Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. The manufacturer…
US job growth during much of the past year was significantly weaker than initially estimated, according to new data released Wednesday. The…
Oracle (NYSE:ORCL) is another beneficiary of the recent AI boom, as its stock performance over the past year can attest. ORCL 5Y…
Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Western investors…
More trouble for Boeing: Tests of its troubled 777X paused after it found structural problems
By Press Room
2 Mins read
The launch of Boeing’s long-delayed 777X aircraft has encountered another problem, forcing the company to pause testing and dealing yet another blow…